Amanda Cray

Investor Relations Contact at FUSN PHAR

Health Technology

Consumer Services

Commercial Services

Profile

Amanda Cray currently works as Senior Director-IR & Corporate Communications at Fusion Pharmaceuticals, Inc. and as Head-Investor Relations at Autolus Therapeutics Plc since 2024.
Former roles include Associate Director-IR & Corporate Communications at Aegerion Pharmaceuticals, Inc. from 2012 to 2019, Director-IR & Corporate Communications at Novelion Therapeutics, Inc. from 2016 to 2019, Senior Account Executive at LaVoie Strategic Communications Group, Inc., Associate at Sharon Merrill Associates, Inc., and Account Manager at Harron & Associates, Inc. Education includes graduate studies at Boston University and undergraduate studies at the University of New Hampshire.

Amanda Cray active positions

Companies	Position	Start
FUSN PHAR	Investor Relations Contact	-
AUTOLUS THERAPEUTICS PLC	Investor Relations Contact	31/10/2024

All active positions of Amanda Cray

Former positions of Amanda Cray

Companies	Position	End
AEGERION PHARMACEUTICALS, INC.	Investor Relations Contact	30/06/2019
NOVELION THERAPEUTICS INC.	Investor Relations Contact	30/06/2019
Sharon Merrill Associates, Inc. Sharon Merrill Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory services	Corporate Officer/Principal	-
Harron & Associates, Inc.	Corporate Officer/Principal	-
LaVoie Strategic Communications Group, Inc. LaVoie Strategic Communications Group, Inc. Advertising/Marketing ServicesCommercial Services Provides strategic communications programs, strategy and brand positioning services	Corporate Officer/Principal	-

See the detail of Amanda Cray's experience

Training of Amanda Cray

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Amanda Cray's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Aegerion Pharmaceuticals, Inc. Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases	Health Technology
Boston University Boston University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of New Hampshire University of New Hampshire Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
LaVoie Strategic Communications Group, Inc. LaVoie Strategic Communications Group, Inc. Advertising/Marketing ServicesCommercial Services Provides strategic communications programs, strategy and brand positioning services	Commercial Services
Sharon Merrill Associates, Inc. Sharon Merrill Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory services	Commercial Services
Harron & Associates, Inc.
Novelion Therapeutics, Inc. Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide	Health Technology
Fusion Pharmaceuticals, Inc. Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer	Health Technology
Autolus Therapeutics Plc Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies	Health Technology